Impact of Smoking Status on Perioperative Morbidity, Mortality, and Long-Term Survival Following Transthoracic Esophagectomy for Esophageal Cancer

被引:20
作者
Kamarajah, Sivesh K. [1 ,2 ]
Madhavan, Anantha [1 ]
Chmelo, Jakub [1 ]
Navidi, Maziar [1 ]
Wahed, Shajahan [1 ]
Immanuel, Arul [1 ]
Hayes, Nick [1 ]
Griffin, S. Michael [1 ]
Phillips, Alexander W. [1 ,3 ]
机构
[1] Newcastle Univ Trust Hosp, Royal Victoria Infirm, Northern Oesophagogastr Unit, Newcastle Upon Tyne, Tyne & Wear, England
[2] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England
[3] Newcastle Univ, Sch Med Educ, Newcastle Upon Tyne, Tyne & Wear, England
关键词
D O I
10.1245/s10434-021-09720-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction Esophagectomy is a key component in the curative treatment of esophageal cancer. Little is understood about the impact of smoking status on perioperative morbidity and mortality and the long-term outcome of patients following esophagectomy. Objective This study aimed to evaluate morbidity and mortality according to smoking status in patients undergoing esophagectomy for esophageal cancer. Methods Consecutive patients undergoing two-stage transthoracic esophagectomy (TTE) for esophageal cancers (adenocarcinoma or squamous cell carcinoma) between January 1997 and December 2016 at the Northern Oesophagogastric Unit were included from a prospectively maintained database. The main explanatory variable was smoking status, defined as current smoker, ex-smoker, and non-smoker. The primary outcome was overall survival (OS), while secondary outcomes included perioperative complications (overall, anastomotic leaks, and pulmonary complications) and survival (cancer-specific survival [CSS], recurrence-free survival [RFS]). Results During the study period, 1168 patients underwent esophagectomy for cancer. Of these, 24% (n = 282) were current smokers and only 30% (n = 356) had never smoked. The median OS of current smokers was significantly shorter than ex-smokers and non-smokers (median 36 vs. 42 vs. 48 months; p = 0.015). However, on adjusted analysis, there was no significant difference in long-term OS between smoking status in the entire cohort. The overall complication rates were significantly higher with current smokers compared with ex-smokers or non-smokers (73% vs. 66% vs. 62%; p = 0.018), and there were no significant differences in anastomotic leaks and pulmonary complications between the groups. On subgroup analysis by receipt of neoadjuvant therapy and tumor histology, smoking status did not impact long-term survival in adjusted multivariable analyses. Conclusion Although smoking is associated with higher rates of short-term perioperative morbidity, it does not affect long-term OS, CSS, and RFS following esophagectomy for esophageal cancer. Therefore, implementation of perioperative pathways to optimize patients may help reduce the risk of complications.
引用
收藏
页码:4905 / 4915
页数:11
相关论文
共 38 条
  • [11] Early complications after Ivor Lewis subtotal esophagectomy with two-field lymphadenectomy: Risk factors and management
    Griffin, SM
    Shaw, IH
    Dresner, SM
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2002, 194 (03) : 285 - 297
  • [12] Validation of a Nomogram Predicting Complications After Esophagectomy for Cancer
    Grotenhuis, Brechtje A.
    van Hagen, Pieter
    Reitsma, Johannes B.
    Lagarde, Sjoerd M.
    Wijnhoven, Bas P. L.
    Henegouwen, Mark I. van Berge
    Tilanus, Hugo W.
    van Lanschot, J. Jan B.
    [J]. ANNALS OF THORACIC SURGERY, 2010, 90 (03) : 920 - 926
  • [13] Overexpression of miR-200c Induces Chemoresistance in Esophageal Cancers Mediated Through Activation of the Akt Signaling Pathway
    Hamano, Rie
    Miyata, Hiroshi
    Yamasaki, Makoto
    Kurokawa, Yukinori
    Hara, Johji
    Moon, Jeong Ho
    Nakajima, Kiyokazu
    Takiguchi, Shuji
    Fujiwara, Yoshiyuki
    Mori, Masaki
    Doki, Yuichiro
    [J]. CLINICAL CANCER RESEARCH, 2011, 17 (09) : 3029 - 3038
  • [14] Anastomotic Leak Does Not Impact on Long-Term Outcomes in Esophageal Cancer Patients
    Kamarajah, S. K.
    Navidi, M.
    Wahed, S.
    Immanuel, A.
    Hayes, N.
    Griffin, S. M.
    Phillips, A. W.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (07) : 2414 - 2424
  • [15] Long-term outcomes of clinical and pathological-staged T3 N3 esophageal cancer
    Kamarajah, S. K.
    Newton, N.
    Navidi, M.
    Wahed, S.
    Immanuel, A.
    Hayes, N.
    Griffin, S. M.
    Phillips, A. W.
    [J]. DISEASES OF THE ESOPHAGUS, 2020, 33 (08)
  • [16] Risk factors and outcomes associated with anastomotic leaks following esophagectomy: a systematic review and meta-analysis
    Kamarajah, Sivesh K.
    Lin, Aaron
    Tharmaraja, Thahesh
    Bharwada, Yashvi
    Bundred, James R.
    Nepogodiev, Dmitri
    Evans, Richard P. T.
    Singh, Pritam
    Griffiths, Ewen A.
    [J]. DISEASES OF THE ESOPHAGUS, 2020, 33 (03)
  • [17] Critical appraisal on the impact of preoperative rehabilitation and outcomes after major abdominal and cardiothoracic surgery: A systematic review and meta-analysis
    Kamarajah, Sivesh K.
    Bundred, James
    Weblin, Jonathan
    Tan, Benjamin H. L.
    [J]. SURGERY, 2020, 167 (03) : 540 - 549
  • [18] Association of Adjuvant Radiotherapy With Survival After Margin-negative Resection of Pancreatic Ductal Adenocarcinoma A Propensity-matched National Cancer Database (NCDB) Analysis
    Kamarajah, Sivesh K.
    Sonnenday, Christopher J.
    Cho, Clifford S.
    Frankel, Timothy L.
    Bednar, Filip
    Lawrence, Theodore S.
    Nathan, Hari
    [J]. ANNALS OF SURGERY, 2021, 273 (03) : 587 - 594
  • [19] Genetic and Epigenetic Alterations in Barrett's Esophagus and Esophageal Adenocarcinoma
    Kaz, Andrew M.
    Grady, William M.
    Stachler, Matthew D.
    Bass, Adam J.
    [J]. GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2015, 44 (02) : 473 - +
  • [20] Oesophageal cancer
    Lagergren, Jesper
    Smyth, Elizabeth
    Cunningham, David
    Lagergren, Pernilla
    [J]. LANCET, 2017, 390 (10110) : 2383 - 2396